Compare IDXX & EQNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IDXX | EQNR |
|---|---|---|
| Founded | 1983 | 1972 |
| Country | United States | Norway |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1B | 63.9B |
| IPO Year | 1991 | N/A |
| Metric | IDXX | EQNR |
|---|---|---|
| Price | $678.36 | $26.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | ★ $700.50 | $28.20 |
| AVG Volume (30 Days) | 445.6K | ★ 5.2M |
| Earning Date | 02-02-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 4.63% |
| EPS Growth | ★ 21.65 | N/A |
| EPS | ★ 12.60 | 2.15 |
| Revenue | $4,167,411,000.00 | ★ $107,066,000,000.00 |
| Revenue This Year | $12.15 | $2.49 |
| Revenue Next Year | $8.72 | N/A |
| P/E Ratio | $54.58 | ★ $12.23 |
| Revenue Growth | ★ 8.39 | 2.15 |
| 52 Week Low | $356.14 | $21.41 |
| 52 Week High | $769.98 | $28.27 |
| Indicator | IDXX | EQNR |
|---|---|---|
| Relative Strength Index (RSI) | 40.21 | 68.76 |
| Support Level | $687.46 | $24.47 |
| Resistance Level | $705.82 | $25.74 |
| Average True Range (ATR) | 14.98 | 0.52 |
| MACD | -2.49 | 0.21 |
| Stochastic Oscillator | 12.27 | 85.55 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2024 (52% liquids) and ended 2024 with 6.1 billion barrels of proven reserves (42% liquids). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.